Centinel Spine Expands STALIF Internationally

Centinel Spine Inc. (Centinel Spine has expanded its Midline II-Ti product family, a Ti-Active-coated, No-Profile, anterior lumbar integrated interbody device in the United States and Australia.
 
Midline II-Ti, the most recent Centinel Spine innovation for anterior lumbar interbody fusion (ALIF) procedures, represents the sixth generation of Stalif technology.  Midline II-Ti blends the Stalif integrated interbody advantage with Ti-Active, a uniquely texturized, microporous titanium plasma coating, to form a novel technology and approach to anterior lumbar interbody fusion (ALIF) procedures with eight degrees, 12 degrees, 16 degrees and 20 degrees of lordosis, excellent radiographic visualization and three cancellous screws for optimum stability.
 
“This expansion is enabling Centinel Spine to rapidly increase market share and represents another key milestone in our Ti-Active product portfolio,” said John J. Viscogliosi, chairman and CEO of Centinel Spine. “Ti-Active is the culmination of over 15 years of titanium coating science, engineering and experience.  And, as with all Centinel Spine technology, Ti-ACTIVE has been designed to satisfy unmet market needs.  There have been over 4,500 Ti-Active devices successfully implanted to date.”
 
Midline II-Ti is based upon the Stalif Midline II product family. Midline II was designed to offer surgeons increased ease of use by reducing the surgical envelope required to implant the device while maintaining the biomechanics underpinning 30 years of Stalif surgical success.  In harmony with Wolff’s law, three strategically configured cancellous screws create additional compression at each treated segment. The Ti-Active coating increases the contact surface area and friction at the bony endplates. To date, roughly 1,000 Midline II devices have been implanted.
 
“The compressive fixation provided by the three lag screws, lordosis options and size options are very important,” said Gunwant Mallik, M.D., of Columbus, Ohio. “The titanium-coated PEEK option provides additional surface area that enhances stability.”
 
“Midline II represents the best ALIF device currently on the market due to the overall simplicity, dependability and comprehensive design rationale,” agreed Jon White, M.D., of the HOAG Orthopedic Institute in Irvine, Calif.
 
Centinel Spine develops, manufactures, markets and sells the complete Stalif product family, which includes Stalif C, Stalif C-Ti for anterior cervical discectomy fusion  procedures and Stalif L for lateral lumbar interbody fusion procedures. Recently, Centinel Spine received U.S. Food and Drug Administration clearance for Altos PCT, a posterior cervical stabilization system specifically designed for use in either the cervical lateral masses or cervical-thoracic pedicles.
 
Centinel Spine is a privately-held developer of stand-alone, No-Profile integrated interbody fusion technologies. The company began operations in August 2008 through the merger-acquisition of Raymedica LLC and Surgicraft Ltd. Centinel Spine derived its name from the “Sentinel Sign”—the radiographic confirmation of a successful fusion anterior to the interbody device.